Jingbiao Chen1,2, Jin Wang3, Jiahui Li1, Jie Chen1, Xin Lu1, Hiroaki Yashiro4, Jenifer Siegelman4, Christopher T Winkelmann4, Richard L Ehman1, Vijay H Shah2, and Meng Yin1
1Radiology, Mayo Clinic, Rochester, MN, United States, 2Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States, 3the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China, 4Research and Development, Takeda Pharmaceuticals International Co., Cambridge, MA, United States
Synopsis
Liver biopsy remains the gold standard for staging liver fibrosis. However,
its invasive nature makes it unacceptable for long-term disease dynamic
monitoring. In addition, current histopathological scoring systems for staging liver
fibrosis are not quantitative. Also, the inflammatory response of increased
interstitial fluid volume is precursory and occult with histological analysis. It
is critical to address the overlooked fluid-associated inflammatory response
and semi-quantitative fibrosis grading. Here, we use a novel
technique, magnetic resonance elastography, combined with ALT, as a noninvasive
quantitative method to quantify and monitor hepatic water and fibrosis content in
a mouse model with varying disease progression/regression.
Introduction
Liver biopsy remains the gold standard for staging liver fibrosis1. However, its
invasive nature makes it unacceptable for long-term dynamic monitoring of inflammation
and fibrosis extent. In addition, the current histopathological scoring systems
are semi-quantitative. Thus, the extent of fibrosis may differ even in the same
fibrosis stage, especially in patients with F>=4, which may lead to
underestimation of anti-fibrotic effect. Indeed, evidence has shown that
quantitative assessment of liver fibrosis did not linearly associate with
fibrosis stage2. Interstitial fluid volume
augmentation (or edema) is a histologically occult process before inflammatory
cellular invasion, which may result in changes of fluid-associated mechanical
response, such as viscosity or loss modulus3,4. Magnetic resonance
elastography (MRE) is a novel technique that can measure the mechanical
properties of the liver. Studies have shown that liver stiffness measured by
MRE correlates well with the progression of liver fibrosis stage5-8. However, whether MRE alone or in combination
with liver function tests can disentangle and quantify liver inflammation and fibrosis
remain unknown. Therefore, the purpose of this preclinical study was to
evaluate the value of multiparametric MRE in combination with liver function
tests in the assessment of liver inflammation and fibrosis progression and
regression in a mouse model.Methods
A
total of 35 wild-type C57BL/6J male mice were studied. Progression of liver
fibrosis was induced by intraperitoneal injection of carbon tetrachloride (CCL4)
twice a week for 2, 3, or 4 weeks. Regression of liver fibrosis was achieved by
withdrawal of CCL4 for 2 or 4 weeks after a 4-week CCL4
treatment. Three corresponding age-matched control groups were included. 3D MRE
at 80 and 200Hz were performed at different time points (baseline, week 2, 3, 4,
6, and 8) in each study group. Multiple mechanical parameters of the liver were
calculated. Mice were weighed and sacrificed after the last MRE scanning. Serum
samples were collected for liver function tests. Liver samples were collected
for biochemistry/physical evaluation of liver fibrosis (hydroxyproline content)
and inflammation (water content). The existence of liver fibrosis was evaluated
histologically with Sirius red staining. The existence of hepatic inflammation
was determined simply by untreated (i.e. age-matched controls) and treated
(i.e., past administration of CCl4 including both progression and
regression) groups. Spearman’s
correlation, univariate and multivariable analyses were performed to identify
the independent MRE and liver function predictors for hydroxyproline and water
extent. Prediction models were generated by adaptive Lasso regression
with AICc validation. Diagnostic accuracies were evaluated by ROC
analysis for screening liver fibrosis and inflammation.Results
Mice liver hydroxyproline and water content increased progressively with
time after the administration of CCl4 and decreased after CCl4
withdrawal (Figure 1). Liver shear
stiffness (SS) and alanine aminotransferase (ALT) increased during disease
progression and decreased during disease regression. However, damping ratio
(DR) fluctuated in individual animals, and there was no
significant difference between groups (Figure
2). In multivariate regression, SS, DR, and ALT were identified as significant
predictors for hydroxyproline, while SS and ALT were identified as significant predictors
for water content. Prediction models for liver hydroxyproline and water content
with different combinations of predictors were shown in Table 1. A model combining SS, DR, and ALT to predict hydroxyproline
showed the best correlation with actual hydroxyproline (r = 0.82, p <
0.0001). The diagnostic accuracy of predicted hydroxyproline for discriminating
fibrosis from non-fibrosis was excellent (AUC = 0.92, p < 0.0001) (Figure
3). Comparing with SS alone, a model combining SS and ALT to predict liver
water content showed better correlation with actual water content (r = 0.71, p
< 0.0001). The diagnostic accuracy of predicted water content for
differentiating diseased from controls was excellent (AUC = 0.91, p <
0.0001) (Figure 4).Discussion
It has been well established that liver stiffness can accurately detect
the progression of liver fibrosis5-8. Our study found
that liver stiffness decreased with the reduction of hepatic fibrosis, which
reinforced the fact that liver stiffness is sensitive to the fibrosis content. Our
study revealed that a model combining SS, DR, and ALT, instead of SS alone, can
better quantify fibrosis content with concurrent inflammation. In our previous
study, we found that DR was associated with liver inflammation9. The statistically insignificant
group differences observed in DR in this study may be attributed to the
biweekly administration of CCl4 and invasive liver needle
penetration needed for MRE. This time-dependent CCL4-induced mouse
model could have substantial fluctuation of inflammatory response in each
individual animal over time. Therefore, the effects of DR and ALT, associated
with liver inflammation or cellular injury, can be disentangled in the
prediction of fibrosis extent. Inflammation or injury to the liver can lead to
increase in the interstitial fluid volume and pressure, and the latter can
increase liver stiffness3,4. Therefore, SS in
combination with ALT can predict liver water content, a surrogate of inflammation.Conclusion
A multiparametric model combining SS and DR, derived from MRE, and ALT can serve as a noninvasive surrogate in detecting and monitoring the progression and regression of liver fibrosis and concurrent inflammation, which has the potential to noninvasively evaluate the efficacy of novel anti-fibrotic/inflammatory treatments in patients. Acknowledgements
This study is supported by NIBIB: EB017197 (M.Y.), NIBIB: EB001981
(R.L.E.), NIAAA: AA021171 (V.H.S.), and Takeda Pharmaceuticals International:
FP00102673 (M.Y.).References
1. Li S, Sun X, Chen
M et al. Liver Fibrosis Conventional and Molecular Imaging Diagnosis Update. J
Liver 2019; 8
2. Masugi Y, Abe T,
Tsujikawa H et al. Quantitative assessment of liver fibrosis reveals a
nonlinear association with fibrosis stage in nonalcoholic fatty liver disease.
Hepatol Commun 2018; 2: 58-68
3. Reed RK, Rubin K.
Transcapillary exchange: role and importance of the interstitial fluid pressure
and the extracellular matrix. Cardiovasc Res 2010; 87: 211-217
4. Wiig H, Swartz MA.
Interstitial fluid and lymph formation and transport: physiological regulation
and roles in inflammation and cancer. Physiol Rev 2012; 92: 1005-1060
5. Xiao G, Zhu S,
Xiao X et al. Comparison of laboratory tests, ultrasound, or magnetic resonance
elastography to detect fibrosis in patients with nonalcoholic fatty liver disease:
A meta-analysis. Hepatology 2017; 66: 1486-1501
6. Shi Y, Xia F, Li
QJ et al. Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis
in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo
Echo Planar Imaging: A Prospective Study. Am J Gastroenterol 2016; 111: 823-833
7. Park
CC, Nguyen P, Hernandez C et al. Magnetic Resonance
Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive
Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty
Liver Disease. Gastroenterology 2017; 152: 598-607 e592
8. Fu F, Li X, Chen C
et al. Non-invasive assessment of hepatic fibrosis: comparison of MR
elastography to transient elastography and intravoxel incoherent motion
diffusion-weighted MRI. Abdom Radiol (NY) 2019, DOI: 10.1007/s00261-019-02140-x
9. Yin
M, Glaser KJ, Manduca A et al. Distinguishing between Hepatic Inflammation and
Fibrosis with MR Elastography. Radiology 2017; 284: 694-705